Safety and Tolerability of BIII 890 in Patients With Acute Ischemic Stroke
Clinical trial NCT02251197 · COMPLETED
Trial details
- NCT number
- NCT02251197
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2001-07-01
- Primary completion
- 2002-10-01
- Enrollment
- 97
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.